Home LiteratureArticle Details
PMID: 2153685 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion.

The Journal of cell biology ·Vol. 110 ·No. 2 ·1990-02-00 ·Pages 529-40

Zimmerman GA, McIntyre TM, Mehra M, Prescott SM

Abstract

The binding of neutrophils (polymorphonuclear leukocytes [PMNs]) to endothelial cells (ECs) presents special requirements in the regulation of intercellular adhesion. ECs that are stimulated by certain agonists, including thrombin and cytokines (tumor necrosis factor alpha, interleukin-1), generate molecular signals that induce the adhesion of PMNs (endothelial cell-dependent neutrophil adhesion). Our experiments demonstrate that the mechanism of binding induced by thrombin is distinct from that induced by the cytokines based on the time courses, the requirement for protein synthesis, and differential binding of HL60 promyelocytic leukemia cells to ECs activated by the two classes of agonists. The rapid EC-dependent PMN adhesion (initiated in minutes) that occurs when the ECs are stimulated by thrombin is temporally coupled with the accumulation of platelet-activating factor, a biologically active phosphoglyceride that remains associated with ECs and that activates PMNs by binding to a cell surface receptor. A portion of the newly synthesized platelet-activating factor (PAF) is on the EC surface, as demonstrated by experiments in which the rate of hydrolysis of PAF synthesized by activated ECs was accelerated by extracellular PAF acetylhydrolase. When ECs were treated with exogenous PAF they became adhesive for PMNs; the PMN binding was prevented by incubating the ECs with PAF acetylhydrolase or by treating the PMNs with competitive PAF receptor antagonists. Thus PAF associated with the EC plasma membrane induces PMN binding, an observation supported by experiments in which PAF in model membranes (liposomes) stimulated rapid PMN adhesion to ECs and to cell-free surfaces. In addition, competitive antagonists of the PAF receptor inhibited the binding of PMNs to ECs activated by thrombin and other rapidly acting agonists, but not to ECs activated by tumor necrosis factor alpha, indicating that PAF that is endogenously synthesized by ECs can mediate neutrophil adhesion. These experiments demonstrate a novel mechanism by which a cell-associated phospholipid, PAF, can serve as a signal for an intercellular adhesive event.

MeSH Terms
Biological Factors/pharmacology Cell Adhesion/drug effects,physiology Cell Communication/drug effects,physiology Cell Membrane/metabolism,ultrastructure Cytokines Endothelium, Vascular/cytology,metabolism,ultrastructure Humans Liposomes/analysis Neutrophils/cytology,metabolism,ultrastructure Phospholipids/metabolism,physiology Platelet Activating Factor/analysis,metabolism,physiology Platelet Membrane Glycoproteins Receptors, Cell Surface/antagonists & inhibitors,metabolism Receptors, G-Protein-Coupled Signal Transduction/physiology Thrombin/pharmacology
Chemicals
Biological Factors Cytokines Liposomes Phospholipids Platelet Activating Factor Platelet Membrane Glycoproteins Receptors, Cell Surface Receptors, G-Protein-Coupled platelet activating factor receptor Thrombin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Zimmerman G A
Nora Eccles Harrison Cardiovascular Research and Training Institute, Salt Lake City, Utah.
McIntyre T M
Mehra M
Prescott S M
References (65)
65 references, click to expand
  1. Intracellular localization of platelet-activating factor synthesis in human neutrophils.
    Biochem Biophys Res Commun. 1988 Aug 15;154(3):1232-9 PMID: 3408495
  2. Neutrophil adherence to human endothelium in vitro occurs by CDw18 (Mo1, MAC-1/LFA-1/GP 150,95) glycoprotein-dependent and -independent mechanisms.
    J Clin Invest. 1988 Feb;81(2):531-7 PMID: 2828429
  3. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.
    J Immunol. 1978 Jan;120(1):109-15 PMID: 342601
  4. Characteristics of human mononuclear phagocytes.
    Blood. 1979 Aug;54(2):485-500 PMID: 454850
  5. (+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist.
    Biochem Biophys Res Commun. 1988 Feb 15;150(3):1213-20 PMID: 2829894
  6. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.
    J Cell Biol. 1986 Mar;102(3):688-96 PMID: 3005335
  7. Monoclonal antibody-defined functional epitopes on the adhesion-promoting glycoprotein complex (CDw18) of human neutrophils.
    Blood. 1986 Apr;67(4):1007-13 PMID: 2420394
  8. Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils.
    Proc Natl Acad Sci U S A. 1986 Apr;83(7):2204-8 PMID: 3457383
  9. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
    Biochim Biophys Acta. 1986 May 21;876(3):373-8 PMID: 3707974
  10. Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies.
    J Immunol. 1986 Jul 1;137(1):15-27 PMID: 3519773
  11. Platelet activating factor: a biologically active phosphoglyceride.
    Annu Rev Biochem. 1986;55:483-509 PMID: 3017194
  12. Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor.
    J Biol Chem. 1986 Oct 15;261(29):13720-6 PMID: 3020044
  13. Neutrophil-induced injury of rat pulmonary alveolar epithelial cells.
    J Clin Invest. 1986 Nov;78(5):1375-86 PMID: 3771800
  14. Studies on the mechanism of interleukin 1 stimulation of platelet activating factor synthesis in human endothelial cells in culture.
    Biochim Biophys Acta. 1987 Jan 19;927(1):43-54 PMID: 3024738
  15. Cloning of the beta subunit of the leukocyte adhesion proteins: homology to an extracellular matrix receptor defines a novel supergene family.
    Cell. 1987 Feb 27;48(4):681-90 PMID: 3028646
  16. Cell-matrix interactions and cell adhesion during development.
    Annu Rev Cell Biol. 1986;2:27-47 PMID: 3548769
  17. Cell adhesion molecules in the regulation of animal form and tissue pattern.
    Annu Rev Cell Biol. 1986;2:81-116 PMID: 3548776
  18. Regulation of transmembrane signaling by receptor phosphorylation.
    Cell. 1987 Mar 27;48(6):913-22 PMID: 3030559
  19. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
    J Biol Chem. 1987 Mar 25;262(9):4215-22 PMID: 3549727
  20. Thrombin stimulates neutrophil adherence by an endothelial cell-dependent mechanism: characterization of the response and relationship to platelet-activating factor synthesis.
    Ann N Y Acad Sci. 1986;485:349-68 PMID: 3471149
  21. Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
    J Immunol. 1987 Jun 15;138(12):4298-302 PMID: 3495589
  22. Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures.
    J Immunol. 1987 Oct 1;139(7):2439-46 PMID: 3116081
  23. Cell adhesion in morphogenesis.
    Annu Rev Cell Biol. 1987;3:319-45 PMID: 3318879
  24. Identification of an inducible endothelial-leukocyte adhesion molecule.
    Proc Natl Acad Sci U S A. 1987 Dec;84(24):9238-42 PMID: 2827173
  25. Transient increase of cytosolic free calcium in cultured human vascular endothelial cells by platelet-activating factor.
    Biochem Biophys Res Commun. 1988 Aug 15;154(3):910-7 PMID: 3408504
  26. The role of lipids in Plasmodium falciparum invasion of erythrocytes: a coordinated biochemical and microscopic analysis.
    Proc Natl Acad Sci U S A. 1988 Aug;85(16):5956-60 PMID: 3045809
  27. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen.
    Proc Natl Acad Sci U S A. 1988 Oct;85(20):7734-8 PMID: 2971974
  28. Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration.
    J Clin Invest. 1988 Nov;82(5):1746-56 PMID: 2903180
  29. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor.
    J Immunol. 1988 Nov 15;141(10):3391-7 PMID: 3263425
  30. Assembly of phospholipids into cellular membranes: biosynthesis, transmembrane movement and intracellular translocation.
    Annu Rev Cell Biol. 1988;4:579-610 PMID: 3058167
  31. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion.
    J Clin Invest. 1988 Dec;82(6):2045-55 PMID: 3198764
  32. Adherence of neutrophils to cultured human microvascular endothelial cells. Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p150,95 glycoprotein family.
    J Clin Invest. 1989 Feb;83(2):637-46 PMID: 2521491
  33. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.
    Science. 1989 Mar 3;243(4895):1160-5 PMID: 2466335
  34. Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma.
    Proc Natl Acad Sci U S A. 1989 Apr;86(7):2393-7 PMID: 2928339
  35. The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C.
    J Biol Chem. 1989 Apr 15;264(11):6325-33 PMID: 2703492
  36. Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects.
    J Clin Invest. 1961 Jun;40:989-95 PMID: 13684958
  37. Lipid asymmetry in membranes.
    Annu Rev Biochem. 1979;48:47-71 PMID: 382989
  38. Uptake and degradation of low density lipoproteins (LDL) by confluent, contact-inhibited bovine and human endothelial cells exposed to physiological concentrations of LDL.
    Atherosclerosis. 1979 Aug;33(4):425-31 PMID: 228681
  39. Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).
    J Immunol. 1981 Sep;127(3):1250-5 PMID: 6267133
  40. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    J Immunol. 1981 Sep;127(3):839-44 PMID: 6790618
  41. The concept of lipid domains in membranes.
    J Cell Biol. 1982 Jul;94(1):1-6 PMID: 6889603
  42. Spontaneous and protein-catalyzed transfer of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) between phospholipid bilayers.
    Biochim Biophys Acta. 1983 Feb 7;750(2):217-22 PMID: 6860678
  43. Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin.
    Proc Natl Acad Sci U S A. 1984 Jun;81(11):3534-8 PMID: 6587368
  44. Uncoupling of the membrane skeleton from the lipid bilayer. The cause of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickled cells.
    J Clin Invest. 1985 Jan;75(1):183-90 PMID: 3965502
  45. Leukocyte-endothelial interactions.
    Blood. 1985 Mar;65(3):513-25 PMID: 3918593
  46. Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.
    Proc Natl Acad Sci U S A. 1985 Feb;82(3):672-6 PMID: 2983307
  47. Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes.
    J Clin Invest. 1985 Jun;75(6):1965-72 PMID: 4008648
  48. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.
    J Clin Invest. 1985 Jul;76(1):271-80 PMID: 2862164
  49. Macrophage activation by PAF incorporated into dipalmitoylphosphatidylcholine-cholesterol liposomes.
    J Biochem. 1985 Apr;97(4):1255-8 PMID: 3839790
  50. Evidence that biosynthesis of platelet-activating factor (paf-acether) by human neutrophils occurs in an intracellular membrane.
    FEBS Lett. 1985 Oct 28;191(2):195-9 PMID: 3932094
  51. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.
    J Clin Invest. 1985 Nov;76(5):2003-11 PMID: 3877078
  52. trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.
    J Biol Chem. 1985 Dec 15;260(29):15639-45 PMID: 2999126
  53. Membrane lipid composition and cellular function.
    J Lipid Res. 1985 Sep;26(9):1015-35 PMID: 3906008
  54. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro.
    J Clin Invest. 1985 Dec;76(6):2235-46 PMID: 4077977
  55. Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters.
    J Immunol. 1986 Jan;136(2):649-54 PMID: 2416819
  56. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.
    Proc Natl Acad Sci U S A. 1985 Dec;82(24):8667-71 PMID: 3866246
  57. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes.
    J Biol Chem. 1988 Mar 5;263(7):3225-33 PMID: 2830276
  58. Identification of platelet-activating factor receptors in P388D1 murine macrophages.
    J Immunol. 1988 Apr 1;140(7):2389-94 PMID: 2832476
  59. Receptor-directed focusing of lymphokine release by helper T cells.
    Nature. 1988 Mar 24;332(6162):378-80 PMID: 2965306
  60. Endothelium from diverse vascular sources synthesizes platelet-activating factor.
    Arteriosclerosis. 1988 May-Jun;8(3):321-31 PMID: 3130833
  61. Evidence for protein-catalyzed transfer of platelet activating factor by macrophage cytosol.
    Biochim Biophys Acta. 1988 Jul 1;961(1):48-52 PMID: 3382692
  62. Antibodies to cell surface ganglioside GD3 perturb inductive epithelial-mesenchymal interactions.
    Cell. 1988 Jul 15;54(2):235-45 PMID: 3292056
  63. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells.
    J Cell Biol. 1988 Jul;107(1):321-31 PMID: 3134364
  64. Effects of platelet activating factor on calcium-lipid interactions and lateral phase separations in phospholipid vesicles.
    Biochim Biophys Acta. 1988 Aug 18;943(2):211-9 PMID: 3401478
  65. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha.
    J Biol Chem. 1988 Aug 25;263(24):11856-61 PMID: 3261295
Article Info
Journal
The Journal of cell biology
Abbr.
J Cell Biol
ISSN
0021-9525
Published
1990-02-00
Pages
529-40
Language
English
Region
United States
NLM ID
0375356
PMCID
PMC2116010
Subset
IM
Grants
NHLBI NIH HHS · HL34127 · United States
NHLBI NIH HHS · HL35828 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com